Status:
TERMINATED
Next-Gen MS: Feed-forward PRO Data for MS Research
Lead Sponsor:
EMD Serono Research & Development Institute, Inc.
Conditions:
Multiple Sclerosis (MS)
Eligibility:
All Genders
18+ years
Brief Summary
This Next Generation learning health system for Multiple Sclerosis (Next-Gen MS) study is a sub-study of the MS-LINK™ Outcomes Study (NCT04735406). The study aims to examine the effects of using feed ...
Eligibility Criteria
Inclusion
- Participants willing and able to provide written informed consent
- Participants with clinical diagnosis of Multiple Sclerosis (MS)
Exclusion
- None
Key Trial Info
Start Date :
November 2 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
February 19 2024
Estimated Enrollment :
1594 Patients enrolled
Trial Details
Trial ID
NCT04907305
Start Date
November 2 2021
End Date
February 19 2024
Last Update
June 6 2024
Active Locations (8)
Enter a location and click search to find clinical trials sorted by distance.
1
Alabama Neurology Associates
Birmingham, Alabama, United States, 35209
2
Georgetown University
Washington D.C., District of Columbia, United States, 20057
3
Atlanta Neuroscience Institute
Atlanta, Georgia, United States, 30327
4
Beth Israel Deaconess Medical Center
Boston, Massachusetts, United States, 02215